Cannabinoids and Sickle Cell
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
Cannabinoids and Sickle Cell
-
Gesprochen von:
-
Von:
Über diesen Titel
During this First Friday conversation, Marijuana Matters talks about Cannabinoids and Sickle Cell Disease (SCD). SCD affects approximately 8% of African Americans, and is characterized by chronic pain and episodic acute pain caused by Vaso occlusive crises, often requiring high doses of opioids for prolonged periods. Evidence is growing that cannabis may help people manage pain from SCD. However, only nine states include sickle cell as an approved health condition for medical marijuana. This conversation was moderated by Marijuana Matters Executive Director Courtney Davis, SCD advocate Demitrious Wyant aka AR the Prophet, and Cannabis Nurse Rebecca Abraham, CEO, and Founder of Acute on Chronic, LLC.
Stay tuned by following Marijuana Matters on these platforms:
- @marijuanamattersdc (IG)
- Marijuana Matters (LinkedIn)
- @socialequitymatters (Facebook)
